Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 4145 | 44.54 |
09:34 ET | 2572 | 44.16 |
09:36 ET | 900 | 43.83 |
09:38 ET | 1495 | 43.865 |
09:39 ET | 300 | 43.87 |
09:41 ET | 400 | 43.91 |
09:43 ET | 939 | 44.1 |
09:45 ET | 100 | 43.965 |
09:50 ET | 2657 | 44.135 |
09:52 ET | 200 | 44.08 |
09:54 ET | 400 | 44.1 |
09:57 ET | 1600 | 44.0819 |
09:59 ET | 100 | 44.07 |
10:01 ET | 1200 | 44.06 |
10:03 ET | 500 | 44.08 |
10:06 ET | 400 | 44.05 |
10:08 ET | 700 | 44.1 |
10:10 ET | 200 | 44.155 |
10:12 ET | 100 | 44.2 |
10:14 ET | 1100 | 44.14 |
10:15 ET | 1900 | 44.27 |
10:17 ET | 800 | 44.26 |
10:19 ET | 1300 | 44.39 |
10:21 ET | 2300 | 44.38 |
10:24 ET | 900 | 44.35 |
10:26 ET | 700 | 44.405 |
10:28 ET | 940 | 44.39 |
10:30 ET | 100 | 44.37 |
10:32 ET | 4210 | 44.46 |
10:33 ET | 900 | 44.485 |
10:35 ET | 800 | 44.525 |
10:37 ET | 1500 | 44.5 |
10:39 ET | 600 | 44.5 |
10:42 ET | 745 | 44.53 |
10:44 ET | 1640 | 44.45 |
10:46 ET | 302 | 44.475 |
10:48 ET | 1600 | 44.53 |
10:51 ET | 500 | 44.46 |
10:53 ET | 1000 | 44.43 |
10:55 ET | 1000 | 44.38 |
10:57 ET | 200 | 44.365 |
11:00 ET | 1500 | 44.355 |
11:02 ET | 300 | 44.325 |
11:04 ET | 900 | 44.395 |
11:06 ET | 700 | 44.365 |
11:08 ET | 400 | 44.35 |
11:09 ET | 2297 | 44.45 |
11:11 ET | 3814 | 44.58 |
11:13 ET | 727 | 44.57 |
11:15 ET | 300 | 44.625 |
11:20 ET | 511 | 44.645 |
11:22 ET | 3119 | 44.709 |
11:24 ET | 7281 | 44.65 |
11:26 ET | 600 | 44.65 |
11:27 ET | 100 | 44.65 |
11:29 ET | 1700 | 44.67 |
11:31 ET | 3188 | 44.75 |
11:33 ET | 3300 | 44.71 |
11:36 ET | 1826 | 44.718 |
11:38 ET | 600 | 44.72 |
11:40 ET | 700 | 44.71 |
11:42 ET | 10870 | 44.77 |
11:44 ET | 1968 | 44.755 |
11:45 ET | 1896 | 44.725 |
11:47 ET | 440 | 44.75 |
11:51 ET | 3323 | 44.75 |
11:54 ET | 1000 | 44.7 |
11:56 ET | 2300 | 44.74 |
11:58 ET | 100 | 44.705 |
12:00 ET | 1700 | 44.665 |
12:02 ET | 1000 | 44.67 |
12:03 ET | 100 | 44.66 |
12:05 ET | 800 | 44.66 |
12:07 ET | 100 | 44.66 |
12:09 ET | 700 | 44.67 |
12:12 ET | 500 | 44.67 |
12:14 ET | 3018 | 44.575 |
12:16 ET | 100 | 44.595 |
12:18 ET | 300 | 44.61 |
12:20 ET | 800 | 44.6 |
12:21 ET | 700 | 44.58 |
12:23 ET | 700 | 44.58 |
12:25 ET | 366 | 44.5703 |
12:27 ET | 1500 | 44.675 |
12:30 ET | 800 | 44.6825 |
12:32 ET | 400 | 44.685 |
12:34 ET | 800 | 44.68 |
12:36 ET | 100 | 44.68 |
12:38 ET | 200 | 44.69 |
12:39 ET | 900 | 44.64 |
12:41 ET | 100 | 44.64 |
12:43 ET | 300 | 44.66 |
12:45 ET | 300 | 44.65 |
12:48 ET | 1200 | 44.655 |
12:50 ET | 800 | 44.64 |
12:52 ET | 1100 | 44.64 |
12:54 ET | 200 | 44.68 |
12:56 ET | 533 | 44.68 |
12:57 ET | 100 | 44.705 |
12:59 ET | 100 | 44.7 |
01:01 ET | 2043 | 44.745 |
01:03 ET | 1200 | 44.68 |
01:06 ET | 400 | 44.66 |
01:08 ET | 1500 | 44.665 |
01:10 ET | 700 | 44.69 |
01:14 ET | 700 | 44.72 |
01:15 ET | 400 | 44.715 |
01:17 ET | 100 | 44.7 |
01:21 ET | 1997 | 44.735 |
01:24 ET | 2350 | 44.7965 |
01:26 ET | 894 | 44.79 |
01:28 ET | 1603 | 44.82 |
01:30 ET | 1300 | 44.75 |
01:32 ET | 900 | 44.695 |
01:33 ET | 1000 | 44.645 |
01:35 ET | 3400 | 44.68 |
01:37 ET | 400 | 44.67 |
01:42 ET | 13550 | 44.64 |
01:44 ET | 2306 | 44.57 |
01:46 ET | 400 | 44.565 |
01:48 ET | 12075 | 44.53 |
01:50 ET | 1500 | 44.575 |
01:51 ET | 800 | 44.54 |
01:53 ET | 300 | 44.585 |
01:55 ET | 1700 | 44.49 |
01:57 ET | 1100 | 44.475 |
02:00 ET | 500 | 44.49 |
02:02 ET | 1738 | 44.49 |
02:04 ET | 600 | 44.47 |
02:06 ET | 800 | 44.485 |
02:09 ET | 3839 | 44.4 |
02:11 ET | 400 | 44.41 |
02:13 ET | 1199 | 44.4 |
02:15 ET | 15505 | 44.425 |
02:18 ET | 14000 | 44.515 |
02:20 ET | 1003 | 44.4756 |
02:22 ET | 200 | 44.495 |
02:24 ET | 1400 | 44.52 |
02:29 ET | 2641 | 44.55 |
02:31 ET | 2600 | 44.59 |
02:36 ET | 2516 | 44.51 |
02:38 ET | 2100 | 44.53 |
02:40 ET | 500 | 44.57 |
02:42 ET | 797 | 44.55 |
02:44 ET | 3631 | 44.5 |
02:45 ET | 1459 | 44.48 |
02:47 ET | 100 | 44.49 |
02:49 ET | 200 | 44.5 |
02:51 ET | 2800 | 44.52 |
02:54 ET | 670 | 44.51 |
02:56 ET | 100 | 44.51 |
02:58 ET | 524 | 44.515 |
03:00 ET | 900 | 44.54 |
03:02 ET | 2400 | 44.529 |
03:03 ET | 4423 | 44.53 |
03:05 ET | 4003 | 44.5 |
03:07 ET | 700 | 44.53 |
03:09 ET | 2200 | 44.535 |
03:12 ET | 300 | 44.53 |
03:14 ET | 100 | 44.51 |
03:16 ET | 800 | 44.54 |
03:18 ET | 100 | 44.535 |
03:20 ET | 2505 | 44.58 |
03:21 ET | 5121 | 44.6 |
03:23 ET | 300 | 44.6 |
03:25 ET | 4285 | 44.61 |
03:27 ET | 1200 | 44.64 |
03:30 ET | 1826 | 44.65 |
03:32 ET | 3600 | 44.66 |
03:34 ET | 1800 | 44.665 |
03:36 ET | 12554 | 44.71 |
03:38 ET | 2800 | 44.58 |
03:39 ET | 1564 | 44.61 |
03:41 ET | 800 | 44.61 |
03:43 ET | 4804 | 44.575 |
03:45 ET | 6174 | 44.68 |
03:48 ET | 2225 | 44.65 |
03:50 ET | 4287 | 44.65 |
03:52 ET | 4393 | 44.67 |
03:54 ET | 6372 | 44.67 |
03:56 ET | 8854 | 44.671 |
03:57 ET | 5596 | 44.715 |
03:59 ET | 147048 | 44.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.5B | -17.4x | --- |
Halozyme Therapeutics Inc | 5.2B | 19.3x | --- |
Intra-Cellular Therapies Inc | 6.7B | -47.8x | --- |
Apellis Pharmaceuticals Inc | 7.1B | -13.1x | --- |
CRISPR Therapeutics AG | 5.6B | -36.0x | --- |
ACADIA Pharmaceuticals Inc | 3.0B | -48.2x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.5B |
---|---|
Revenue (TTM) | $787.6M |
Shares Outstanding | 145.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-2.56 |
Book Value | $2.68 |
P/E Ratio | -17.4x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.